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Annemieke M. Apergis-Schoute, and Rainer DöfﬁngerBackground: Infectious diseases are the most common and cost-intensive health complications associated with drug addiction. There is
wide belief that drug-dependent individuals expose themselves more regularly to disease-related pathogens through risky behaviors
such as sharing pipes and needles, thereby increasing their risk for contracting an infectious disease. However, evidence is emerging
indicating that not only lifestyle but also the immunomodulatory effects of addictive drugs, such as cocaine, may account for their high
infection risk. As feelings of disgust are thought to be an important psychological mechanism in avoiding the exposure to pathogens, we
sought to investigate behavioral, physiological, and immune responses to disgust-evoking cues in both cocaine-dependent and
healthy men.
Methods: All participants (N ¼ 61) were exposed to neutral and disgust-evoking photographs depicting food and nonfood images while
response accuracy, latency, and skin conductivity were recorded. Saliva samples were collected before and after exposure to neutral and
disgusting images, respectively. Attitudes toward disgust and hygiene behaviors were assessed using questionnaire measures.
Results: Response times to disgust-evoking photographs were prolonged in all participants, and speciﬁcally in cocaine-dependent
individuals. While viewing the disgusting images, cocaine-dependent individuals exhibited aberrant skin conductivity and increased the
secretion of the salivary cytokine interleukin-6 relative to control participants.
Conclusion: Our data provide evidence of a hypersensitivity to disgusting stimuli in cocaine-dependent individuals, possibly reﬂecting
conditioned responses to noningestive sources of infection. Coupled with a lack of interoception of bodily signals, aberrant disgust
responses might lead to increased infection susceptibility in affected individuals.Key Words: Conditioned immunoactivation, cytokines, drug
addiction, interleukin (IL)-6, infection susceptibility, interoception
One of the most serious and costly health complicationsassociated with drug addiction is the risk of contracting ortransmitting infectious diseases (1–5). Reducing the dispro-
portionately high rate of infection in chronic drug users has long
been a priority target of harm-reduction policies (6). Although the
introduction of needle-exchange schemes has been successful for
intravenous cocaine users, harm reduction remains a challenge for
users who snort cocaine or inhale crack-cocaine (7–9). For instance,
hepatitis C rates of up to 80% have been estimated in crack-cocaine
smokers (6). Risky behaviors such as sharing unsterile straws or
pipes, engaging in unprotected sex, or personal hygiene inadequa-
cies have been considered to account for the increased prevalence
of infections in noninjecting users (10–12). Yet several studies have
failed to ﬁnd relationships between these risky behaviors and
infection rates in this population (10,13), suggesting that factors
other than lifestyle may account for their high infection risk.
Emerging evidence indicates that addictive drugs have immu-
nomodulatory effects that may decrease drug users’ ability toFrom the Department of Psychiatry (KDE, CCH, PSJ, AMA-S) and
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http://dx.doi.org/10.1016/j.biopsych.2013.08.004ﬁght infections (14–17). Cocaine has been shown to alter immune
cell activity and cytokine production (18,19), leading to the
suppression of innate immune responses (20,21). Conversely,
cocaine has also been shown to prolong inﬂammation, possibly
through neuroendocrine interactions (22), which could facilitate
the development of systemic low-grade inﬂammation (23,24).
Current strategies to tackle the high infection rates in chronic
drug users focus primarily on remediating harm, although
proactive approaches strengthening protective mechanisms
might be more desirable.
Self-care behaviors are one vital means through which
infectious diseases can be prevented. A critical mechanism
underlying the development of avoidant and protective self-
care strategies are learned relationships between cues signaling
sickness, feelings of disgust, and unconditioned immune
responses (25–27). Stimuli evoking feelings of disgust can induce
bodily sensations of revulsion and nausea, eliciting a desire to
withdraw from disgust-evoking cues (28,29). Stimuli that typically
convey the so-called “core” or “pathogen disgust” are rotten food,
decomposing organic matter, poor hygiene, and body products
(30,31). Repeated encounters with disgusting stimuli, and the
feelings of sickness they elicit, may be necessary to associate
these evocative memory traces with avoidance or hygienic
behaviors (27,32). As the central nervous system actively commu-
nicates with the immune system, Pavlovian conditioning to
disgust-evoking cues can be observed in both behavioral and
immune responses (26,33,34). For example, Schaller and col-
leagues examined blood samples of healthy volunteers who were
exposed to either infection- or gun-related photographs (35).
Subsequent in vitro stimulation of these blood samples with
bacterial lipopolysaccharide (LPS) showed that samples provided
by volunteers who were exposed to the disease-related photo-
graphs had a signiﬁcantly greater increase in the cytokine
interleukin-6 (IL-6) compared with those in the control condition.BIOL PSYCHIATRY 2014;75:140–147
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matory processes in response to acute infection (36;37). The
authors suggested that participants’ prior experience with patho-
gens associated with the infectious diseases shown in the
photographs may have triggered an anticipatory response that
facilitated the release of IL-6 (35).
Several studies have shown that cocaine directly suppresses
production of IL-6 in the blood during acute infection (20,21), but
little is known of how cocaine-dependent individuals (CDIs)
respond to cues signaling infection. Salivary immune responses
are of particular interest because the mouth is a major gateway of
microbial infection and mucosal immunity, which is independent
from the rest of the peripheral lymphoid immunity (38). In the
current study, we measured disgust-induced behavioral, physio-
logical, and immune responses in CDIs and healthy volunteers to
investigate two contrasting hypotheses of infection risk in CDIs. It
is possible that CDIs are insensitive to disgust-evoking cues,
thereby failing to anticipate risks of infection and exposing
themselves to pathogens. If this hypothesis were correct, we
would predict blunted disgust processing in the cocaine group,
along with self-reports showing little reﬂection on disgusting
experiences and poor hygienic practices. Alternatively, CDIs could
show conditioned hypersensitive responses to disgust-evoking
stimuli because of their frequent history of infection, but they fail
to use this information appropriately to guide their behavior. If
this hypothesis were correct, we would predict increased
responses to stimuli predictive of infection in the cocaine group
but no difference from the control group in terms of cognitive
and behavioral strategies relating to risks of infection.Methods and Materials
Participants
Sixty-ﬁve men were recruited within the local community
upon referral from probation ofﬁcers, health care professionals,
advertisements, or word-of-mouth. For inclusion, participants had
to be male, 20 to 60 years of age, and able to read and write in
English. Drug-dependent volunteers had to satisfy the DSM-IV-TR
(39) criteria for cocaine dependence, whereas healthy control
volunteers were required to have no personal or family history of
substance misuse disorders. Exclusion criteria for all volunteers
included a lifetime history of a psychotic disorder, neurological
illness or traumatic head injury, an autoimmune or metabolic
disorder, or HIV infection. All volunteers consented in writing and
were screened for current psychiatric disorders using the Mini-
International Neuropsychiatric Inventory (40). Psychopathology in
drug users was further evaluated using the Structured Clinical
Interview for DSM-IV (41). Current negative emotional states were
measured using the Depression Anxiety Stress Scale (DASS-21)
(42); verbal IQ was estimated using the National Adult Reading
Test (NART) (43). The protocol was approved by the National
Research Ethics Committee (NREC10/H0306/69, Principal Investi-
gator: K.D. Ersche) (44).
The 35 CDIs met the DSM-IV-TR criteria for cocaine depend-
ence, but none were actively seeking treatment for cocaine use.
Urine samples tested positive for stimulants in all but four users,
indicating they had consumed cocaine or amphetamines within
the past 72 hours (45). To avoid potentially confounding effects of
drug abstinence, we restricted subsequent analysis to those with
a stimulant-positive urine screen, leaving 31 CDIs in the sample.
Participants reported using cocaine for an average of 15 years
(7.9 SD), mainly intranasally or by inhalation; approximately onequarter of users (23%) injected cocaine intravenously
(Supplement 1). The majority of CDIs also met criteria for
dependence on another substance (93% nicotine, 45% opiates,
29% alcohol, 23% cannabis, 3% amphetamines) and used other
drugs sporadically (51% cannabis, 19% sedatives, 16% ecstasy, 6%
opiates, 3% hallucinogens; see Supplement 1 for details on
sporadic and prescription drug use).
Thirty healthy control participants were screened for drug and
alcohol misuse, and none met criteria for abuse or dependence.
Urine samples were negative for illicit substances in all individ-
uals. Seventy percent were either past or current tobacco
smokers, and 57% reported having social experiences with
cannabis; none reported taking prescribed or illicit drugs on a
regular basis.
Procedures
Participants were assessed at the Wellcome Trust Clinical
Research Facility, Addenbrooke’s Hospital, Cambridge, United
Kingdom. Biological samples and ﬁtness assessments were taken
on arrival to establish health status. Urine samples were tested for
current infection with cytomegalovirus (CMV) and Epstein-Barr
virus, persistent viruses that affect the immune system (46). Blood
samples were drawn to measure serum levels of C-reactive
protein (CRP) as a marker of inﬂammation (47). We used saliva
sampling as a noninvasive method to measure changes in
cytokine levels before and after exposure to neutral and
disgust-evoking photographs; a method that has been used
successfully in previous studies (48,49). At three time points
during their visit, participants were asked to rinse their mouth
with water to provide a 2-mL sample of saliva by passive drool
through a straw into a cryovial (http://www.salimetrics.com).
Samples were provided on arrival (t1), immediately after exposure
to neutral photographs (t2), and immediately after exposure to
disgust-evoking photographs (t3); the samples were frozen at
−801C before being analyzed for the following cytokines: IL-6, IL-
1beta (IL-1β), and tumor necrosis factor-alpha (TNF-α), which are
typically induced together during an infectious challenge (36,37).
We also examined interferon-gamma (IFN-γ) and IL-12, two TH1-
cytokines with important roles in both cellular and innate
immunity (50); the anti-inﬂammatory cytokine IL-10; and IL-8, a
pro-inﬂammatory neutrophil chemotactic factor (51).
Before the exposure procedures, participants completed two
questionnaires to assess interindividual differences in disgust
reactions. The Disgust Propensity-Sensitivity Scale—Revised (52)
is a trait measure of disgust, in which participants rated on a
5-point Likert scale the frequency of affective experiences of
disgust and the cognitive evaluation of these experiences. The
Hygiene Inventory (HI-23) (53) is a measure to assess various
aspects of hygiene-related behaviors, including hand-washing,
personal grooming, food handling, and household cleanliness.
Evocative Task
Participants were shown 120 colored photographs, half
depicting images of neutral valence (neutral foods, household
items) and the other half showing disgusting images (rotten/
moldy foods, dirty objects, dead bodies/animals, disease/injury,
body products). The photographs were selected from a pool of
180 pictures either downloaded from the Internet or selected
from the International Affective Picture Series (54). To ensure the
correct valence classiﬁcation, all pictures were rated for pleasant-
ness, arousal, disgust, and nausea on a Likert scale (1 ¼ not, 7 ¼
very) by 15 healthy men before experimental testing (Table S1 in
Supplement 1). The Wilcoxon signed-rank test conﬁrmed thatwww.sobp.org/journal
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signiﬁcantly with regard to ratings of pleasantness, arousal,
disgust, and nausea (all ps  .001).
The task was administered in two segments (neutral, disgust)
with an intervening period of approximately 40 minutes
(Figure 1). The neutral images always preceded the disgusting
images to obviate a potential carryover effect of disgust-induced
cytokine increases to the neutral condition. Each segment
consisted of 100 trials (50 food, 50 nonfood) shown to partic-
ipants in two separate blocks (food, nonfood). The differentiation
between food and nonfood images reﬂected two routes of
transmission: ingestion versus contact. Each block contained 30
images, during which a random selection of 20 images was
shown twice. The order of the block to be shown ﬁrst (food or
nonfood) was randomized to control for order effects, and the
presentation sequence of images within each block was pseudo-
randomized to avoid consecutive repetition of the same image.
Each photograph was displayed in the center of the computer
screen for 6 seconds, followed by a 3-second interstimulus
interval during which participants were asked to indicate by
button press whether they had seen the picture before; a means
to ensure that participants attended to the images. The 3-second
interval was maintained irrespective of participants’ response
speed. We recorded median latencies of correct responses and
detection accuracy, which was calculated from the hit rate minus
the false alarm rate divided by the number of trials (55). We
sought to investigate differential responses to disgusting versus
neutral images.
Physiological Measures
Skin conductance responses (SCRs) were measured at 1000 Hz
using a BiopacSystems operating AcqKnowledge-4.1 (MP36R,
BiopacSystems, Santa Barbara, California). SCRs were identiﬁed
within a 7-second window after the onset of each stimulus;
minima were identiﬁed within the ﬁrst 1.5 seconds and maxima
between .5 and 7 seconds. To remove high-frequency spikes, data
was zero-phase ﬁltered within a time window of 1000 milli-
seconds. Low-pass ﬁltering was applied within a time window of
200 milliseconds at a cutoff of .01, which provided a baseline for
correcting phasic changes in SCRs. Reponses in microsiemens
were locally normalized as a percentage of the mean of the
phasic response within the 7-second window. Stimuli that elicitedFigure 1. The evocative task includes 120 different photographs, divided int
segment always preceded the disgust segment by approximately 40 minutes. E
photographs depicting various nonfood items; 20 photographs from each categ
nonfood photographs). Participants were asked to indicate by button press w
accuracy and skin conductivity were recorded during each segment. For the co
points: on arrival; immediately after the neutral segment; and immediately aft
www.sobp.org/journalno positive change or a response of less than 2% were classed as
generating no SCRs. Individuals’ median SCR of correct responses
for each category and valence were calculated. Due to technical
difﬁculties, complete data sets of both neutral and disgust
segments were only available from 39 participants (20 controls,
19 cocaine) of 50 recorded data sets. Demographics of partic-
ipants with missing data did not signiﬁcantly differ from the rest
of the sample.
Statistical Data Analysis
Data were analyzed using Statistical Package for the Social
Sciences v.20 (IBM SPSS Statistics, IBM Corporation, Armonk, New
York). Independent sample t tests were used for group compar-
isons on demographic variables, vital signs (pulse, blood pres-
sure), and CRP levels; for infection status, we used Fisher’s exact
test. In preparation for parametric analyses, DASS-21 scores, CRP
levels and cytokine data were square-root transformed to reduce
skew (56); untransformed values are displayed in ﬁgures and
tables. To obviate potential confounding effects of group differ-
ences in mood states and inﬂammatory markers on immune
responses (57–59), DASS-21 total scores and CRP levels were
included as covariates in all group comparisons. Intelligence
levels (as indicated by NART scores) differed signiﬁcantly between
groups, yet the presence of a group interaction precluded the use
of NART scores as a nuisance covariate (60).
We used multivariate analyses of covariance (ANCOVA) to
examine group differences on the Disgust Propensity-Sensitivity
Scale—Revised and Hygiene Inventory questionnaires. We sub-
sequently applied separate repeated-measures ANCOVA models
including accuracy and latency, or SCR data with stimulus
category (food, nonfood) and stimulus valence (neutral, disgust),
as the two within-subject factors and group (controls, cocaine) as
the between-subject factor. The conservative Greenhouse-Geisser
correction was used if the Mauchly’s test showed violations of
sphericity.
For the cytokine analysis, we ﬁrst compared salivary samples
provided at t1 using multivariate ANCOVA to verify the absence of
group differences at baseline. We then used repeated-measures
ANCOVA to examine changes in cytokine levels before and after
provocation procedures, with time-point (t1, t2, t3) as the within-
subject factors and group as the between-subject factor. We
implemented two separate contrasts in the model to directlyo two segments according to their valance (neutral, disgust). The neutral
ach segment consisted of 30 photographs depicting different foods and 30
ory were shown twice, resulting in 100 trials per segment (50 food and 50
hether they had seen the photograph before. Response time, detection
llection of the cytokine data, saliva samples were collected over three time
er the disgust segment.
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(neutral) and t2 versus t3 (disgust) where signiﬁcant interactions
were identiﬁed.
To obviate potentially confounding effects of concomitant
medication, intravenous drug use, comorbid opiate dependence,
and comorbid alcohol dependence, we reanalyzed the data
excluding the following conditions: 1) volunteers who reported
taking prescribed medication (n ¼ 12), 2) individuals who were
CMV-positive/invalid (n ¼ 2), 3) intravenous drug users (n ¼ 7),
4) individuals with comorbid opiate dependence (n ¼ 14), or
5) individuals with comorbid alcohol dependence (n ¼ 9). If not
stated otherwise, Pearson’s correlation coefﬁcient was calculated
for descriptive purposes. All statistical tests were two-tailed, and
signiﬁcance levels were set at .05.
Biomarker Analysis
Biological samples were analyzed at Addenbrooke’s Hospital
Biomedical Campus (http://www.cuh.org.uk). Serum CRP levels
were determined using the particle-enhanced turbidimetric
immunoassay technique (RCRP-[DF34]Flex reagent cartridge;
Dade-Behring, Milton-Keynes, United Kingdom). Salivary cytokines
were measured using the MSD-7-plex-ultra-sensitive human pro-
inﬂammatory cytokine kit (K15008C-2), which was supplied by
MesoScale Discovery (Gaithersburg, Maryland). Urine samples
were screened for the presence of CMV or Epstein-Barr virus
using real-time Taqman polymerase chain reaction assays.Results
Demographics and Clinical Variables
The groups were well matched for age (t59 ¼ .46, p ¼ .650),
but CDIs had signiﬁcantly lower NART scores compared with
their healthy peers (t43.8 ¼ .53, p  .001). The groups did not
differ on vital signs, including pulse rate (t59 ¼ 1.15, p ¼ .253),
systolic (t59 ¼ –.19, p ¼ .847) and diastolic blood pressure
(t59 ¼ .85, p ¼ .399), indicating that the CDIs were not acutely
intoxicated. CDIs, however, scored signiﬁcantly higher on all
three subscales of the DASS-21, reﬂecting increased levels of
depressive mood (F1,55 ¼ 35.8, p  .001), anxiety (F1,55 ¼ 33.9,
p  .001), and stress (F1,55 ¼ 25.0, p  .001). The groups did not
differ in terms of self-reported hygienic behaviors (F1,53 ¼ 1.07,
p ¼ .305), disgust propensity (F1,53 ¼ 1.17, p ¼ .285) or disgust
sensitivity (F1,50 ¼ .36, p ¼ .552).
Although a larger number of CDIs (19%) compared with
control volunteers (7%) reported having more than three colds
per year, this difference was not statistically signiﬁcant (Fishers’
p ¼ .255); information regarding the frequency of other infections
was not collected. CDIs also reported having more difﬁculties
ﬁghting infections (Fishers’ p ¼ .011) and used antibiotic
medication more frequently (Fishers’ p ¼ .053) compared with
their healthy peers. For descriptive data, see Table S2 in
Supplement 1. Laboratory tests revealed a positive CMV infection
in one control volunteer and an invalid test in one drug user; no
evidence was found of Epstein-Barr virus infection in either group.
We measured increased CRP levels in blood serum in the cocaine
group (mean 6.3 mg/L  6.1 SD) compared with the control
group (mean 3.0 mg/L  3.8 SD; t59 ¼ –3.13, p ¼ .003).
Disgust-induced Behavioral and Physiological Responses
Performance data and physiological responses are shown in
Table S3 in Supplement 1. Response latencies were prolonged in
all participants to disgusting images compared with neutralimages, as reﬂected by a signiﬁcant main effect of valence
(F1,48 ¼ 7.64, p ¼ .008); no main effects of valance were observed
for accuracy or SCRs. No main effects of group and stimulus
category were found with regard to accuracy, latency, or SCRs. A
signiﬁcant three-way interaction of category-by-valence-by-group
was identiﬁed on response latency (F1,48 ¼ 4.59, p ¼ .037;
Figure 2A) due to CDIs exhibiting longer response times to
disgusting nonfood pictures relative to neutral nonfood pictures
compared with controls (F1,50 ¼ 4.24, p ¼ .045). Latency changes
for food-related photographs were nonsigniﬁcant (F1,49 ¼ .04, p ¼
.838). There was also a signiﬁcant three-way category-by-valence-
by-group interaction on SCRs (F1,35 ¼ 6.27, p ¼ .017). CDIs showed
signiﬁcantly increased SCRs to disgusting nonfood relative to
neutral nonfood images compared with control participants (F1,35
¼ 5.06, p ¼ .031; Figure 2B); SCRs to food photographs were
nonsigniﬁcant (F1,35 ¼ 2.32, p ¼ .137).
Baseline and Disgust-induced Immune Responses
Descriptive data is shown in Table S4 in Supplement 1. Salivary
cytokine samples provided on arrival did not differ between
groups (p  .1), except for IL-6 (F1,53 ¼ 6.14, p ¼ .016),
with baseline levels signiﬁcantly increased in CDIs. Group com-
parisons across the three time-points revealed a signiﬁcant main
effect of time for IL-1β (F2,106 ¼ 7.82, p ¼ .001), TNF-α
(F1.5,78 ¼ 6.21, p ¼ .007), IL-6 (F1.3,68 ¼ 6.13, p ¼ .010), IL-10
(F1.6,84 ¼ 4.84, p ¼ .016), and IFN-γ (F1.7,90 ¼ 6.75, p ¼ .003). A
signiﬁcant main effect of group emerged for IL-6 (F1,53 ¼ 13.03,
p ¼ .001). We also identiﬁed a signiﬁcant time-by-group inter-
action for IL-6 (F1.3,68 ¼ 6.97, p ¼ .006) and IL-1β (F2,106 ¼ 4.42,
p ¼ .017). Post hoc contrasts conﬁrmed that changes in IL-6 were
signiﬁcant between the neutral (t2) and disgust (t3) conditions
(F1,53 ¼ 6.06, p ¼ .017) but not between arrival (t1) and the neutral
(t2) condition (F1,53 ¼ 1.16, p ¼ .287). Post hoc contrasts for IL-1β
were nonsigniﬁcant. On further inspection, one CDI showed
increased overall levels in cytokine concentration for IL-10, IL-
12p70, IL-6, and TNF-α, deviating by almost 2 SD from the group’s
mean; performance and questionnaire data for this individual
were inconspicuous. After excluding this individual from the analysis,
all main effects and the interaction of IL-6 remained signiﬁcant but
not the interaction for IL-1β (Table S4 in Supplement 1).
Exclusion of participants using prescribed medication or
with CMV-positive status did not change any of the aforemen-
tioned results, nor did the exclusion of participants who used
drugs by injection. Following the removal of either comorbid
alcohol or opiate-dependent individuals from the sample, the
valence-by-category-by-group interaction for SCRs was no
longer signiﬁcant.
Relationships Between Measures of Disgust-induced Change
Only in CDIs we found signiﬁcant relationships between the
different measures of disgust-induced change (i.e., difference
scores): In the nonfood condition, the disgust-induced increase
in SCRs and response accuracy were signiﬁcantly correlated (r ¼
.48, p  .05); in the food condition, CDIs were not aroused during
disgust-provocation, and the disgust-induced decrease in SCRs
was marginally correlated with the increase in IL-6, as measured
at the end of the disgust block (r ¼ −.38, p ¼ .085). No
relationships were identiﬁed with self-report measures. In further
exploring cocaine users’ responses to food stimuli, we observed
signiﬁcant relationships between disgust-induced decrease in
SCRs and overall IL-6 levels (r ¼ −.43, p  .05) and between
disgust-induced change in response latency and the frequency of
cocaine use (Spearmen’s r ¼ .61, p  .001).www.sobp.org/journal
Figure 2. The graphs display differences between disgust minus
neutral trials separately for food and nonfood pictures. (A) Disgust
provocation prolonged the response times in all volunteers, and
speciﬁcally in cocaine-dependent individuals, who showed a signiﬁ-
cant slowing in response speed during the presentation of disgusting
nonfood pictures. (B) The viewing of disgusting nonfood pictures
signiﬁcantly increased SCRs in the cocaine group but not in control
volunteers. (C) Cytokine levels were measured following the exposure
to neutral and disgusting pictures but not following the food and
nonfood blocks. In comparison to healthy volunteers, cocaine-depen-
dent individuals showed a signiﬁcant increase in interleukin-6 (IL-6)
following provocation of disgust compared with the neutral condition.
(The group comparison of salivary IL-6 does not include the data of
the individual with overall extreme levels of pro-inﬂammatory
cytokines).
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The results of the present study provide compelling evidence
of a hypersensitivity to stimuli conveying a risk of infection in
cocaine-dependent individuals. Concurrent with the notion that
feelings of disgust evoke an instant sensory rejection (30), all
participants exhibited prolonged response times when presented
with disgust-evoking photographs; responses to disgusting non-
food images were particularly slow in the cocaine group
(Figure 2A). While viewing the disgusting nonfood pictures, the
cocaine group exhibited increased SCRs (Figure 2B), reﬂecting
increased sympathetic tone (61). They also showed a signiﬁcant
increase in the secretion of salivary IL-6 during the disgust
provocation (Figure 2C), possibly indicating an anticipatory
mechanism to an imminent infectious challenge (25,35,62).
Potential Mechanisms Underlying a Hypersensitivity to
Disgust
At ﬁrst glance, the upregulated IL-6 response to disgust-evoking
stimuli in the cocaine group might be difﬁcult to reconcile with the
immunosuppressive effects of cocaine (20,21); however, at closer
inspection, this contradiction can be explained by conditioned
autonomic responses. Anticipatory immune responses often result
from Pavlovian conditioning, that is, they are acquired through
repeated pairings of a stimulus with an immunomodulatory agent
(25). Consequently, anticipatory responses are observed in individ-
uals with regular exposure to inﬂammatory challenges, for example,
in cancer patients before undergoing their next cycle of chemo-
therapy (63–65). Analogous conditioned learning may thus underlie
the upregulation of salivary IL-6 in CDIs when presented with
photographs of infectious sources, irrespective of IL-6 levels in
peripheral blood (not measured in this study). Recurrent infections
are likely to strengthen associations between infectious stimuli and
innate immune responses (25,34). We therefore believe that the
abnormal behavioral, autonomic and immune reactions measured
in the cocaine group reﬂect conditioned responses to non-ingestive
sources of infection. These conditioned responses may not neces-
sarily be indicative of cocaine users’ compromised immunity.
The autonomic nervous system regulates the process of saliva-
tion (66), so IL-6 is increased in response to stress or during septic
shock (67), suggesting that the observed IL-6 increase is mediated
by nonspeciﬁc stress responses. IL-6 is one of the major cytokines
that interacts with the sympathetic nervous system and
hypothalamic-pituitary-adrenal axis (68). Disgust-provoking photo-
graphs have been shown to activate sympathetic tone in healthy
individuals, as measured by SCRs (69,70). In the present study,
cocaine-dependent individuals exhibited a signiﬁcant increase in
SCRs in response to disgusting, relative to neutral, nonfood photo-
graphs (Figure 2B), which was signiﬁcantly associated with improved
detection of disgusting, relative to neutral, nonfood photographs.
Since cocaine is known to acutely stimulate sympathetic activity
(71,72), one may speculate whether regular cocaine use sensitizes
the sympathetic system, rendering individuals more susceptible to
psychological or physiological arousal (73,74) and thereby facilitates
the secretion of salivary innate immune responses (75).
Differential Responses to Disgusting Food and Nonfood
Stimuli
Hypersensitive disgust-responses in the cocaine group were
speciﬁc to nonfood stimuli, supporting the notion of different
types of disgust. As disgust is elicited by a variety of cues in
different contexts, different functions of disgust for survival have
been hypothesized (28,30,31). Ingestive disgust evoked by spoiled
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in contrast to feelings of disgust induced by body products,
prompting the individual to avoid contact with infectious sources,
thereby helping to prevent disease (31). Reduced appetite is a
common manifestation of acute infectious illness, which is trig-
gered by the release of pro-inﬂammatory cytokines such as IL-6
(76,77). The overall increases in salivary IL-6 levels in the cocaine
group may be indicative of low-grade inﬂammation and associated
sickness behavior, which could explain the lack of arousal in CDIs
while viewing disgusting food images. Importantly, this model of
sickness behavior does not contradict the development of hyper-
sensitivity to noningestive stimuli through classical conditioning.
Methodological Issues and Limitations
Potential limitations of the study include the concurrent use
of other drugs in the majority of CDIs, which may also affect
immune signaling (15). As polydrug use is extremely common in
CDIs (78), it is difﬁcult, if not impossible, to parse out the extent to
which our ﬁndings are confounded by the immunomodulatory
effects of drugs other than cocaine. However, given our aim to
elucidate mechanisms that may be associated with increased
susceptibility for infection in this population, polydrug use in the
present sample may actually serve to enhance the generalizability
of our results. Additional measures of cytokine levels in circulating
blood would have been desirable to complement the salivary
measures. We also acknowledge that other factors associated
with the lifestyle of CDIs, such as malnutrition or insomnia (79,80),
might modulate inﬂammation (81,82) but have not been
addressed in the present study.
In conclusion, our data indicate that CDIs are more sensitive to
cues signaling noningestive sources of infection, which were not
related to drug-taking but depicted general scenes involving dirt,
decay, wounds, and bodily excrement. Increased physiologic
arousal during the viewing of the disgust-evoking cues is likely
to have mediated the upregulation of salivary IL-6 in the cocaine
group (67,75). We have no evidence to assume that CDIs actively
approach these kinds of disgusting and infectious situations; in
fact, their hypersensitive reactions suggest that they might have
been less successful than their healthy peers at avoiding such risks.
Indeed, the observed hypersensitivity in behavioral, autonomic,
and immune responses in cocaine users was not reﬂected in their
attitudes towards disgust and hygiene behavior, as one would
expect of individuals at risk for infection. This reconciles with the
notion of compromised interoception associated with cocaine
dependence (83–86). Disruptions in interoceptive processes may
have profound implications on general health and well-being if
interoceptive feedback is not used to guide behavior. Given that
CDIs do not associate their drug use with heightened risk for
infection (87), and, as our data suggest, do not act on bodily
signals, they are likely to continue exposing themselves to
pathogens; as exempliﬁed by continuing to share drug para-
phernalia, even if sterile equipment is freely available (88).
Although we did not directly test this hypothesis, our ﬁndings
suggest that harm-reduction approaches alone are insufﬁcient to
reduce the high infection rate associated with cocaine depend-
ence. Education about infection risk and training of interoceptive
awareness are potential interventions to be considered. None-
theless, more research is clearly warranted to break the vicious
cycle of infections in addiction.
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